CAS 149-17-7
:Ftivazid
- 4-Pyridinecarboxylic acid, ((4-hydroxy-3-methoxyphenyl)methylene)hydrazide
- 4-Pyridinecarboxylic acid, ((4-hydroxy-3-methoxyphenyl)methylene)hydrazide (9CI)
- 4-Pyridinecarboxylic acid, 2-[(4-hydroxy-3-methoxyphenyl)methylene]hydrazide
- Brn 0234808
- Ftivazid
- Ftivazida
- Ftivazida [INN-Spanish]
- Ftivazide [INN]
- Ftivazidum
- Ftivazidum [INN-Latin]
- Isonicotinic acid vanillylidenehydrazide
- N'-[(3-methoxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]pyridine-4-carbohydrazide
- N'-[(E)-(3-methoxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]pyridine-4-carbohydrazide
- N'-[(Z)-(3-methoxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]pyridine-4-carbohydrazide
- N-Isonicotinamido-3-methoxy-4-hydroxybenzalimine
- Nsc 31725
- Phthivazid
- Phthivazide
- Phthivazidum
- Phtivazid
- Phtivazide
- Unii-40Q4C3O4V0
- Vancide
- Vanicid
- Vanillaberon
- Vanizide
- Ftivazide
- 4-22-00-00598 (Beilstein Handbook Reference)
- Weitere Synonyme anzeigen
Isonicotinic Acid Vanillylidenehydrazide
CAS:Kontrolliertes ProduktApplications Isonicotinic Acid Vanillylidenehydrazide exhibits anti-mycobacterial activity against Mycobacterium tuberculosis and anti-microbial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Candida albicans, and Aspergillus niger.Also, it is derived from Isoniazid (I821450), which is an antibiotic for treatment of Mycobacterium tuberculosis, inhibits mycolic acid biosynthesis. Metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. Selectively induces expression of CYP2E1. Reversibly inhibits CYP2C19 and CYP3A4 activities, and mechanistically inactivates CYP1A2, CYP2A6, CYP2C19 and CYP3A4 at clinically relevant concentrations. Antibacterial (tuberculostatic).
References Judge, V., et al.: Med. Chem. Res., 21, 1451-1470 (2012); Brewer, G.A., et al.: Anal. Profiles Drug Subs., 6, 183 (1977), Weber, W.W., et al.: Clin. Pharmacokinet., 4, 401 (1979)Formel:C14H13N3O3Farbe und Form:NeatMolekulargewicht:271.27Phthivazid
CAS:Phthivazid is an antibiotic, which is a synthetic derivative of isonicotinic acid hydrazide. It functions by inhibiting the synthesis of mycolic acids in the mycobacterium cell wall, which are essential components for the survival of the bacteria. This disruption in the cell wall synthesis results in bactericidal activity against Mycobacterium tuberculosis.Formel:C14H13N3O3Reinheit:90% MinFarbe und Form:PowderMolekulargewicht:271.27 g/mol



